Metropolitan Life Insurance Company (MetLife)’s Core Molding Technologies CMT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CMT Stock Details CMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-428	Closed	-$8.1K	–	458
2024 Q1	$8.1K	Hold	428	–	–	﹤0.01%	2200
2023 Q4	$7.93K	Hold	428	–	–	﹤0.01%	2244
2023 Q3	$12.2K	Hold	428	–	–	﹤0.01%	2129
2023 Q2	$9.74K	Buy	+428	New	+$8.31K	﹤0.01%	2312

Other funds holding CMT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CMT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Core Molding Technologies (CMT) in Q2 2024, closing a stake of 428 shares — an estimated $8.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CMT in Q2 2023 and held it in 4 quarters. The position peaked at $12.2K in Q3 2023. 88 funds tracked by Wall St. Rank hold CMT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Core Molding Technologies position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 428 Core Molding Technologies shares in Q2 2024, an estimated $8.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Core Molding Technologies in Q2 2023 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Core Molding Technologies position peaked at $12.2K in Q3 2023.
88 funds tracked by Wall St. Rank held Core Molding Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.